Bulgaria Pharmaceuticals & Healthcare Q4 2020
Bulgaria continues to make progress in the streamlining of its drugs supply chain and stabilising its pricing regimes. Atthe same time, the new proposals in the 2020 budget that aim to address issues with social security and healthcare funds reflectsthe current administration's ambition to address the long-term structural problems of Bulgaria's health system. Despite this,continued socioeconomic and industry-specific factors mean that opportunities for multinational pharmaceutical companiesremain limited.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook